CMB International Capital

CMB International Capital Corporation is an investment banking firm based in Central, Hong Kong, that specializes in a wide array of financial services. Founded in 1987 as a subsidiary of China Merchants Bank, the firm offers comprehensive services including mergers and acquisitions, initial public offerings, equity underwriting, and corporate restructuring. It also provides project financing, business consulting, and various forms of debt financing. CMB International Capital serves a diverse clientele, comprising institutional, corporate, and individual clients both domestically and internationally. The firm is equipped to assist with share placements, refinancing for listed companies, and transaction advisory services, making it a versatile player in the financial services sector.

Kexiang Zhou

Managing Director

108 past transactions

Dynanonic

Post in 2025
Shenzhen Dynanonic Co., Ltd., established in January 2007, specializes in the development and industrialization of nanomaterials, focusing on nano-scale lithium-ion battery materials. The company integrates research and development with production and sales, positioning itself as a national high-tech enterprise. Headquartered in Nanshan District, Shenzhen, Dynanonic operates R&D and production facilities in Foshan City, Guangdong Province, Feicheng City, Shandong Province, and Pingshan District, Shenzhen. Through its commitment to advancing nanotechnology, Dynanonic aims to contribute to various industrial applications and innovations in energy storage solutions.

Damo Intelligent Control

Series A in 2025
Damo Intelligent Control is a national specialized "little giant" enterprise and a national high-tech enterprise focusing on the research and development, production, sales, and service integration of drone cluster automation performance systems. It is the world's leading supplier of drone cluster automation performance systems.

Naen Auto

Venture Round in 2024
Shanghai NAEN Auto Technology Co., Ltd. specializes in the development and manufacturing of automotive electronics tailored for automobile manufacturers. The company offers a range of advanced products including passive entry passive start systems, electronic steering column locks, smart air conditioning systems, body control modules, heads-up display systems, domain control units, capacitive sensors, and kick sensors. By providing these innovative solutions, NAEN Auto enables automotive manufacturers to enhance the intelligence and functionality of their vehicles.

Aiper

Series B in 2024
Pool cleaners of all types have been around as long as there have been pools; Aiper is the new kid on the block with a lot to prove. How would we make up the gap? By constantly innovating, throwing everything we have into R&D to raise the quality of your pool at every level. We do every test, have developed dozens of sensors and hundreds of algorithms, all ageared to making your pool experience the best, most effortless experience possible – that is the Aiper promise. With over one million dollars in crowdfunding, more than any other cordless robotic pool cleaning product, people are taking notice.

Tianchen Biotechnology

Series A in 2024
Tianchen Biotechnology is a biotechnology company focused on the development and sale of medical products for ophthalmology. It offers a range of diagnostic and treatment solutions, including portable ophthalmic equipment for patients and comprehensive care systems for medical institutions, aiming to enhance eye health.

Hengyu Biotechnology

Series B in 2024
Hengyu Biotechnology is a specialized provider of biological testing services aimed at drug developers. Founded by a scientific research team, the company focuses on delivering comprehensive biosafety testing solutions for innovative pharmaceutical companies worldwide. Its services include viral clearance process validation, cell bank validation, replicative virus testing, batch release testing, CGT bioanalysis, and process residue testing. These offerings are designed to meet regulatory filing requirements across the United States, China, and Europe, supporting the entire life cycle of biologics from research and development to marketing.

Yundao Zhizao

Series C in 2024
Yundao Zhizao develops the general multi-physics simulation PaaS platform and creates a controllable general simulation engine. They provide simdroids and engineering module development. They serve the petroleum and petrochemical industries, aerospace, automobiles, shipbuilding, weapons, nuclear energy, rail transit, and other key industries.

BIODEP

Venture Round in 2024
Biodep is a Chinese biotechnology company based in Wuxi, dedicated to producing probiotics and their derivatives. These products are utilized across various industries including food processing, health foods, cosmetics, environmental remediation, modern agriculture, and others.

Zhongke Hydroyi

Seed Round in 2023
Zhongke Hydroyi focuses on the research and development of polymer diaphragm products.

Alpha Better

Series A in 2023
Alpha Better specializes in compound semiconductor wafer-level inspection equipment. The company is dedicated to improving the yield control level of semiconductor material substrates, epitaxy, and chips through the use of optical detection methods. Yiben's foundation is material analysis and characterization technology, with photonic optics and artificial intelligence at its core, and it provides quantitative, standardized, and intelligent detection tools to help China's semiconductor industry break through the historical development process.

AutoCore

Series B in 2023
AutoCore is a provider of intelligent mobility software and automotive electrical and electronic architecture solutions. The company specializes in developing an automotive middleware platform designed to support next-generation vehicles. Its offerings include operating systems and autonomous driving software tailored for various automotive computing platforms. AutoCore assists Original Equipment Manufacturers (OEMs) and Tier 1 suppliers throughout the entire product life cycle, from design to production, ensuring that automotive innovations meet the evolving demands of the industry.

KHAT

Series C in 2023
KHAT is a developer and producer of electronically controlled suspension for passenger vehicles.

Hongdao New Materials

Series A in 2023
Hongdao New Materials is a technology-based company that specializes in the research, development, production, and sale of solar module packaging film materials.

Red Sun Optoelectronics

Venture Round in 2023
Red Sun Optoelectronics is a state-owned high-tech enterprise specializing in photovoltaic equipment, intelligent manufacturing system integration applications, R&D, and production.

Neurophth Therapeutics

Series C in 2023
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Singsun

Series A in 2023
Singsun is a service provider focusing on providing advanced smart photovoltaic tracking support system solutions and intelligent manufacturing.

Continental hydrogen production

Venture Round in 2023
Continental involved in development, designing, manufacturing and management of hydrogen production equipment and gas purification equipment.

China Reserve National Energy

Series A in 2023
China Reserve National Energy is a developer of air energy storage technology. This technology has the advantages of large scale, low cost, long life, clean and pollution-free, unlimited energy storage period, independent of fossil fuels and geographical conditions, etc.

INTAMSYS

Series B in 2023
INTAMSYS Technology Co. Ltd. is a Shanghai-based company that specializes in the design and manufacture of 3D printers and additive manufacturing systems. The company focuses on high-performance functional materials, offering advanced 3D printing solutions tailored for various sectors, including aerospace, automotive, medical, engineering, oil and gas, and education. INTAMSYS's flagship products, the FUNMAT HT and FUNMAT PRO HT printers, are engineered for affordability and high performance, meeting the needs of functional materials 3D printing. In addition to manufacturing printers, INTAMSYS provides comprehensive additive manufacturing services, including the creation of functional prototypes, tooling, fixtures, and mass production of final products. All INTAMSYS printers adhere to strict quality standards and have received necessary certifications, ensuring reliability and performance in diverse industrial applications.

CyweeMotion

Series B in 2023
CyweeMotion specializes in perception fusion technology and solutions aimed at enhancing consumer electronics. The company focuses on the development of somatosensory technology, offering a range of products for smart wearables, earwear, the Internet of Things (IoT), and augmented/virtual reality (AR/VR). Utilizing a nine-axis fusion sensor method, CyweeMotion's technology is integrated into wearable devices such as smartwatches and fitness bracelets, enabling advanced motion detection and health monitoring features. This innovative approach allows for more accurate real-time motion data calibration, improving the assessment of sports performance while minimizing power consumption and reducing data transmission delays.

Obsbot

Series C in 2023
Obsbot uses revolutionary technology and innovative products to innovate the way public records are created and images are created and to change people's social ways. Its focus areas include visual intelligence based on deep learning, computer photography, and intelligent shooting technologies. It sells an artificial intelligence camera for recording and image creation.

Yinjia Biotechnology

Series A in 2023
Yinjia Biotechnology is a technology platform company devoted to source innovation and introduction, cooperation, and development, with an engagement in the widespread use of proteins in biomedicine and other major livelihood fields. The early stages of development, products, and services such as diagnosis, vaccines, key core raw materials for new drugs, and cell therapy.

Zhide New Energy

Series B in 2023
Zhide New Energy is a developer of approaches to synthetize new silicon anode materials. They focuses on silicon technology that can be applied to produce new materials. They also produce battery with high energy density and low cost. They manufactures battery for 3C and EV. They provide batteries for fields, such as electric vehicles, consumer electronics, house power storage, and wearable devices.

KM Soft

Venture Round in 2022
KM Soft software is used in equipment manufacturing enterprises such as aviation, aerospace, aviation development, shipbuilding, electronics, automobiles, and construction machinery. Their software product center includes digital platforms, digital research and development, digital process, digital manufacturing, and 3D tool software.

Microquanta

Series D in 2022
Microquanta, based in Hangzhou, specializes in the development and manufacturing of perovskite solar cell modules, which represent an innovative approach to solar technology. These modules are designed to deliver higher electricity conversion rates at lower costs compared to traditional solar technologies. The company's latest perovskite mini-module achieves an electricity conversion rate of 17%, surpassing its previous record of 16%. With a total funding of $10 million secured, Microquanta aims to further commercialize its technology and establish production lines within the year. By offering high energy conversion efficiency, the company provides flexible clean energy solutions to its business clients.

.bit

Series A in 2022
.bit provides a globally unique account system with the .bit suffix. The leading technical architecture of .bit allows both blockchain and non-blockchain users to use it without permission. .bit’s “cross-chain” feature is achieved in a way of cryptography-level security. As a DID system, .bit meets the ultimate requirements of Web3.0. .bit makes your asset transfer more convenient and secure. It can serve as the unified username in different Dapps. It can be used as a portal for Dapps. It provides you with a decentralized personal homepage (.bit.cc). It bridges the gap between Web2.0 and Web3.0. Discord:https://discord.gg/did Twitter:https://twitter.com/dotbitHQ Medium: https://dotbit.medium.com/ GitHub: https://github.com/dotbitHQ Forum:https://talk.did.id/

Comet Crystal New Materials

Series B in 2022
Comet New Materials provides thermal interface materials, electromagnetic shielding, and absorbing materials, die-casting alloy materials, and ceramic products.

Xita Technology

Series A in 2022
Hangzhou Xita Technology Co., Ltd. specializes in providing blockchain integrated solutions aimed at facilitating digital upgrades for various industries, including government entities, large state-owned enterprises, universities, and research institutions. Founded in 2019 and headquartered in Hangzhou, China, with additional branches in Beijing, Guangzhou, and Shanghai, the company offers a range of products to enhance business operations. Its offerings include RivSpace, a blockchain infrastructure product, RivTrust, which enables secure data element transfer, and CITA, an open-source underlying platform, along with CITA-Cloud, a development framework. These solutions are designed to help organizations efficiently build web 3.0 applications, improve customer acquisition, and increase operational efficiency.

ATAPEX

Series A in 2022
ATAPEX specializes in the large-scale mass production of precision metal masks essential for the fabrication of OLED panels and other high-end display technologies. The company addresses the challenges faced by its clients, such as limited product options, inconsistent quality, and lengthy delivery times. Its product portfolio includes advanced solutions like Divide Open Masks and Fine Metal Masks for AMOLED displays, as well as Micro OLED Open Masks designed for silicon-based OLED applications. By integrating these products into a cohesive industry chain, ATAPEX aims to enhance the performance and reliability of display manufacturing processes, thereby supporting the needs of various display terminal sectors, including virtual and augmented reality technologies.

Basic Semiconductor

Series C in 2022
BASiC Semiconductor Ltd. is a China-based company founded in 2016 that focuses on the development and industrialization of silicon carbide (SiC) power devices. Operating within the wide-band gap semiconductor industry, BASiC Semiconductor is dedicated to research and development, with multiple R&D centers located in Shenzhen, Beijing, Nanjing, Wuxi, and Nagoya, Japan. The company boasts a highly skilled R&D team, which includes over ten PhD holders from prestigious institutions such as the University of Cambridge and Tsinghua University. BASiC Semiconductor offers a comprehensive range of services, including material preparation, chip design, manufacturing processes, packaging, and testing of advanced semiconductors. By doing so, it aims to enhance electrical performance and reduce costs for its clients in various sectors, including electronics and automotive industries.

Huashun Xin'an

Series C in 2022
Huashun Xin'an develops internet security systems for enterprise cybersecurity protection. It specializes in developing network security systems that focus on big data cyberspace mapping to provide effective cybersecurity solutions for enterprises and governments. The core technical capabilities of the company have been continuously improved through black production portraits, big data correlation and analysis, and research on offensive and defensive technologies, which can provide users with continuous and reliable cyberspace security construction and security services.

Rona Therapeutics

Series A in 2022
Rona Therapeutics is an innovative RNA therapeutics platform focused on the discovery, development, and commercialization of modular and programmable RNA medicines. The company specializes in oligonucleotide therapies, RNA editing, and polymeric molecules, aiming to create transformative RNA therapies that can significantly impact disease treatment across various therapeutic areas. Rona Therapeutics is committed to developing proprietary technologies that enhance the specificity, stability, and longevity of therapeutic effects. To support its mission, the company is establishing state-of-the-art facilities to advance nucleic acid synthesis, delivery platforms, and RNA biology. Through its efforts, Rona Therapeutics seeks to improve patient health outcomes and foster an environment conducive to innovation and excellence in RNA medicine.

METiS Pharmaceuticals

Series B in 2022
Jitai Medicine (METiS) is a biotechnology company that uses artificial intelligence to drive drug delivery and drug discovery. It combines advanced technologies like artificial intelligence, machine learning, and quantum simulation to achieve more effective design of innovative delivery materials, drug candidate selection and formulation design, "programmable nucleic acid drug" development, and nucleic acid delivery design.

METiS Therapeutics

Series B in 2022
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

HemaCell

Seed Round in 2022
HemaCell is a biotechnology company specializing in cell therapy, specifically focused on regenerating hematopoietic lineages, which include blood and immune cells, through advanced in vitro techniques. Leveraging innovative stem cell reprogramming, editing, and differentiation technologies, HemaCell aims to address the critical shortage of platelets necessary for treating various diseases such as cancer, liver disease, critical illness, and hematological disorders. The company employs a unique platform that utilizes platelets as drug delivery carriers, facilitating the rapid establishment of induced pluripotent stem cells (iPSCs) and gene targeting technologies. In addition to platelet production, HemaCell is dedicated to developing novel therapeutic solutions for diseases associated with platelet abnormalities, thereby offering effective treatment options and addressing significant medical needs.

Innoscience

Series D in 2022
Innoscience (Zhuhai) Technology Co Ltd. is a semiconductor company based in Zhuhai, China, founded in 2015. It specializes in the development and production of third-generation semiconductor power electronic devices, focusing primarily on gallium nitride (GaN) technology. As an integrated device manufacturer, Innoscience produces a range of GaN products, including discrete chips, integrated circuits, wafers, and modules. These products cater to various sectors, such as consumer electronics, renewable energy, industrial applications, automotive electronics, and data centers. The company's offerings are designed to provide high-frequency performance and low on-resistance, addressing the needs of modern power semiconductor applications.

ABclonal

Series D in 2021
ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

Jiahe Jinwei

Series B in 2021
Jiahe Jinwei has an industry-leading R&D team and several fully automated high-speed SMT production lines. Provide a full range of high-quality products and solutions such as memory modules, SSD solid state drives, various storage devices; at the same time, products are widely used in mobile terminals, personal computers, communication equipment, industrial control computer systems, enterprise-level servers, data centers, Cloud storage, etc.; also provide customers with special customized services to meet market differentiated and innovative needs. The company has set up factories and R&D centers in Shenzhen and Taiwan, and set up multiple laboratories for material testing, compatibility testing, reliability testing, and chip debugging experiments, covering an area of ​​more than 8,000 square meters.

Neurophth Therapeutics

Series C in 2021
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Ultraleap

Series D in 2021
Ultraleap Limited is a leading developer of mid-air haptic control systems and 3D hand tracking technology. Formerly known as Ultrahaptics, the company specializes in creating solutions that utilize ultrasound to generate tactile sensations, enabling users to feel three-dimensional shapes and textures without physical contact. Its flagship products include the Leap Motion Controller, which captures hand movements, and the VR Developer Mount, designed for enhancing virtual reality experiences on various headsets. The company's innovative technology is applicable across multiple industries such as extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment. Established in 2013 and headquartered in Bristol, United Kingdom, Ultraleap also has a subsidiary in Silicon Valley, United States.

Hypersics Semiconductor

Series A in 2021
Hypersics Semiconductor is a prominent semiconductor company based in Yizheng, China, specializing in the research, development, and industrialization of 6-inch silicon carbide substrates. The company is dedicated to integrating overseas innovative technologies with domestic industrial resources to advance its capabilities. Hypersics has assembled a strong team by recruiting overseas returnees and foreign experts, ensuring high-level expertise in its R&D efforts.

Huasun Energy

Series A in 2021
Huasun Energy, founded in 2020 and based in Hefei, China, focuses on the production and sales of high-efficiency silicon heterojunction solar cells and components. The company specializes in heterojunction technology and is dedicated to research and development in this field. By promoting the use of solar energy, Huasun Energy plays a significant role in advancing the green energy industry, contributing to a more sustainable future through its innovative solar solutions.

SJ Semi

Series C in 2021
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.

Amador Bioscience

Series B in 2021
Amador Bioscience is a contract research organization that specializes in providing translational sciences and clinical pharmacology services to biopharmaceutical companies. Their core offerings include bioanalysis and biomarker services, which support drug development by measuring drug concentrations and identifying biomarkers relevant to specific diseases or therapies. Additionally, they provide clinical research services, assisting clients with the design, conduct, and analysis of clinical trials. Amador Bioscience also offers consulting services in areas such as clinical pharmacology, medicine validation, and regulatory submission, helping pharmaceutical companies navigate the complexities of drug development and approval processes.

Sineva

Private Equity Round in 2021
Hefei Sineva Intelligent Machine Co., Ltd., established in 2013 and located in Hefei, China, specializes in the research, development, manufacturing, and sales of transfer, test, and service robots. The company operates under the umbrella of Zhejiang Qianjiang Biochemical Co., Ltd. Sineva focuses on providing AI-based machine vision solutions and advanced materials that cater to semiconductor production and drug development. Its business encompasses four main areas: intelligent manufacturing machinery, advanced materials, artificial intelligence, and aircraft. By addressing critical technical gaps in the domestic pan-semiconductor industrial robot sector, Sineva positions itself as a key player in the evolving landscape of intelligent manufacturing.

XINYI Information Technology

Series B in 2021
XINYI Information Technology Ltd., established in 2017 with headquarters in Shanghai, China, specializes in designing, developing, and selling system integration and IoT communication chips for the radio frequency simulation industry. Its flagship product is the XY1100 CMOS chip. The company also offers technical consulting services and electronic product development. XINYI operates R&D centers in Shanghai, Nanjing, Chengdu, and Singapore, along with sales offices across China and a supply chain center in Hong Kong. Led by alumni of renowned communication chip companies like Broadcom and Qualcomm, XINYI boasts comprehensive international chip R&D capabilities.

Jyss Bio

Series B in 2021
Jyss Bio is a developer of disposable bioreactors and peripheral equipment.

Thoth Medical

Series C in 2021
Thoth Medical is a developer of innovative medical wearables that integrate advanced biomedical sensor technology. The company focuses on combining wireless transmission technology, artificial intelligence algorithms, and cloud monitoring systems to enhance patient care. Thoth Medical is dedicated to delivering precise, efficient, comfortable, and safe clinical medical services, aiming to improve health outcomes through its cutting-edge wearable devices.

Ultipa

Series A in 2021
Ultipa is a pioneering hard-tech company founded by experienced entrepreneurs from Silicon Valley, specializing in the development of advanced graph database technologies. The company has created the world's fastest 4th generation graph database system, aimed at transforming enterprise digital operations through graph-augmented intelligence. Ultipa's product offerings include the Ultipa Graph database, Ultipa Manager, and a suite of turnkey applications addressing various sectors such as Risk Management, Asset Liability Management, and Liquidity Management. By integrating graph computing and knowledge graph technologies, Ultipa enables organizations to extract maximum value from complex data sets, effectively replacing traditional relational databases and big-data frameworks. The company serves numerous prominent clients, including major banks, stock exchanges, and large enterprises. In November 2022, Ultipa launched Ultipa Cloud, a database-as-a-service and software-as-a-service version of its graph database, further enhancing its market presence.

Clustar

Series A in 2021
Clustar is an artificial intelligence computing platform service provider. Bohai Nebula applies super-calculated research and technical results to the commercial field, providing an efficient distributed machine learning system for enterprise AI. At present, Xingyun Clustar is a project-based way to help companies land, with a unit price of one million yuan. For some enterprises with weak information and intelligence, Xingyun also provides integrated software and hardware solutions, including Ethernet RDMA + intelligent network card / self-developed switch

Abiochem Biotechnology

Series C in 2021
Abiochem Biotechnology is a high-tech enterprise specializing in enzyme engineering and genetic engineering technologies. The company focuses on the research and development of biocatalytic and synthetic biology methods, aiming for their application in large-scale production. Its innovations are utilized across various sectors, including pharmaceuticals, agriculture, and food, contributing to advancements in green chemistry. Abiochem Biotechnology offers customized genetic and enzyme engineering services, positioning itself as a leader in bio-intelligent manufacturing and the development of chemical and biological products.

PackGene Biotech

Series C in 2021
PackGene Biotech is a leading Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) based in the United States, specializing in viral vectors for gene therapies. The company excels in developing adeno-associated virus (AAV) vectors, mRNA, plasmid DNA, and lentiviral vector solutions. PackGene Biotech offers comprehensive services from vector design and construction to AAV, lentivirus, and mRNA production. With a focus on early-stage drug discovery, preclinical development, and cell and gene therapy trials, the company provides cost-effective, reliable, and scalable production solutions for medical industry researchers.

Qihan Biotech

Series A in 2021
Qihan Biotech is a biomedical company specializing in genetic technology with a focus on addressing the global shortage of organ donors. The company aims to produce safe and effective cells, tissues, and organs for human transplantation using advanced gene editing techniques. By applying these technologies to xenogenic organ transplantation, Qihan Biotech seeks to create organs that can be transplanted into humans, thereby reducing the need for traditional organ transplants and saving lives.

YuanHua Zhineng

Series A in 2021
YuanHua Zhineng specializes in sophisticated medical and intelligent service robots. The company provides a robot system for orthopedic surgery that can help surgeons with a variety of procedures, including spine, knee/hip replacement, trauma, and knee/hip replacement.

EpimAb Biotherapeutics

Series C in 2021
EpimAb Biotherapeutics, based in Shanghai, China, is a biopharmaceutical research and development company focused on creating innovative bispecific antibody therapeutics, particularly for immuno-oncology. Utilizing its proprietary Fabs-In-Tandem Immunoglobulin (FIT-Ig) platform, EpimAb develops bispecific antibodies that combine the properties of two different monoclonal antibodies into a single molecule. This unique approach aims to address the limitations of traditional antibody therapies, offering potential solutions for various life-threatening diseases, including cancer. The company recognizes the challenges associated with developing bi-specific antibodies, such as maintaining their drug-like properties and ensuring adequate production. By advancing its pipeline of bispecific therapeutics, EpimAb seeks to meet the growing demand for effective treatment options in the pharmaceutical industry.

Guoquan Shihui

Series D in 2021
Guoquan Shihui is a prominent food supplier in China, specializing in hot pot and barbecue ingredients. The company operates a supermarket convenience store chain that provides a wide range of products, including casual snacks, fresh food, and prepared meal options. By utilizing both B2B and B2C models, Guoquan Shihui addresses the needs of small and medium-sized catering enterprises while also catering to consumers seeking convenient meal solutions for home dining. With a well-curated product portfolio, the brand emphasizes ready-to-eat, ready-to-heat, and ready-to-cook items, making it easier for families to enjoy delicious meals at home. The company boasts a vast network of nearly 10,000 retail stores across China, ensuring accessibility and affordability for a diverse customer base. Through its robust supply chain and production capabilities, Guoquan Shihui effectively enhances the dining experience for consumers looking for convenience and quality in their meal choices.

Newlink

Series E in 2021
Newlink is a digital energy service provider focused on advancing the energy Internet of Things (EIoT) and developing an innovative energy retail platform. Recognized as one of the world's leading new energy companies, it operates across various energy sectors, including oil, electricity, hydrogen, and gas. With a workforce exceeding 3,000 employees, Newlink aims to digitally transform the energy industry by integrating upstream and downstream processes and enhancing the energy ecosystem. The company creates a digital middle platform that facilitates efficient and convenient smart energy supply, incorporating refueling and charging services into the smart systems of major domestic original equipment manufacturers (OEMs).

CotheraBio

Venture Round in 2021
CotheraBio develops innovative cancer therapies with a focus on translational oncology. It has developed its proprietary i-CR® technology platform, which is a powerful method for providing individualized drug screening and new drug development. The platform combines a high content screening system with the conditional reprogramming of primary cultured tumor cells, which enables the efficient and undifferentiated expansion of primary patient-derived tumor cells in vitro, while also preserving the tumor’s heterogeneity.

Innoscience

Series C in 2021
Innoscience (Zhuhai) Technology Co Ltd. is a semiconductor company based in Zhuhai, China, founded in 2015. It specializes in the development and production of third-generation semiconductor power electronic devices, focusing primarily on gallium nitride (GaN) technology. As an integrated device manufacturer, Innoscience produces a range of GaN products, including discrete chips, integrated circuits, wafers, and modules. These products cater to various sectors, such as consumer electronics, renewable energy, industrial applications, automotive electronics, and data centers. The company's offerings are designed to provide high-frequency performance and low on-resistance, addressing the needs of modern power semiconductor applications.

Codemao

Series D in 2020
Codemao is an online education platform focused on teaching children the fundamentals of computer coding. Established in 2015 in Shenzhen, Guangdong, by Tianchi Li and Yue Sun, Codemao utilizes a proprietary visual programming tool that enables students to engage with coding through gamified courses. This innovative approach combines digital learning with various disciplines, allowing children to grasp programming concepts while developing their logical thinking and creative skills. The platform facilitates the creation of games, software, animations, and stories, fostering an interactive learning environment. Additionally, Codemao promotes collaboration through its dynamic online community, enhancing teamwork abilities among young learners.

SmartSens Technology

Series B in 2020
SmartSens Technology is a company based in Shanghai that specializes in the research, development, design, and sales of high-performance CMOS image sensor chips. The company offers advanced imaging solutions applicable in various sectors, including surveillance, machine vision, automotive, and mobile cameras. With a commitment to innovation, SmartSens aims to enhance growth across multiple industries by providing a diverse and comprehensive portfolio of image sensors.

Dingdang Kuaiyao

Series B in 2020
Dingdang Kuaiyao is an online-to-offline drug purchasing and delivery platform. After users place orders on the mobile app, drugs will be delivered to their homes within half an hour.

InventisBio

Series D in 2020
InventisBio Inc. is a biotechnology company focused on discovering and developing innovative therapeutics for cancer and metabolic diseases. Founded in 2013 and based in Pudong, China, the company has developed a range of small molecule drug candidates targeting lung cancer, breast cancer, and gout. Among its notable products is D-0316, a third-generation EGFR-T790M tyrosine kinase inhibitor. InventisBio is also engaged in creating targeted immuno-oncology therapies that can be used in combination with existing treatments, such as PD-1 antibodies, to address various cancer indications. Co-founded by Dr. Yaolin Wang and a team of scientists with extensive experience in drug discovery at major pharmaceutical companies, InventisBio aims to provide effective therapies for significant health challenges.

Biocytogen

Series D in 2020
Biocytogen LLC is a biotechnology company based in Worcester, Massachusetts, that specializes in developing gene-targeted animal models for life science research. Founded in 2008, the company offers a range of services, including customized and off-the-shelf mouse models, phenotype analysis, and advanced gene-editing techniques. Its products encompass various types of mice, such as knockin and knockout models, as well as humanized mice, catering to diverse research areas including immunology, neurology, cancer, and infectious diseases. Biocytogen also operates a state-of-the-art animal facility to support its integrated platform for efficient antibody drug discovery and validation. The company collaborates with leading pharmaceutical and biotechnology firms to enhance preclinical research and development processes in the biomedical field.

Haihe Biopharma

Series B in 2020
Haihe Biopharma is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative anti-tumor drugs aimed at addressing complex diseases. The company specializes in pharmacological efficacy evaluation and offers a range of products, including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors. Through its research and development efforts, Haihe Biopharma seeks to enhance health outcomes and the quality of research for its customers, providing effective solutions in the fight against cancer.

BYD Semiconductor

Series A in 2020
BYD Semiconductor is an electronic components manufacturing company that specializes in the research and development of power semiconductors and integrated device manufacturer (IDM) solutions. The company produces a diverse range of products, including battery management chips, power field effect transistors, image sensors, touch control chips, protection diodes, and current sensors. BYD Semiconductor's offerings are designed to serve various industries such as automotive, energy, industrial, and consumer electronics, focusing on the sensing, processing, and control of optical, electrical, and magnetic signals.

Codemao

Series C in 2020
Codemao is an online education platform focused on teaching children the fundamentals of computer coding. Established in 2015 in Shenzhen, Guangdong, by Tianchi Li and Yue Sun, Codemao utilizes a proprietary visual programming tool that enables students to engage with coding through gamified courses. This innovative approach combines digital learning with various disciplines, allowing children to grasp programming concepts while developing their logical thinking and creative skills. The platform facilitates the creation of games, software, animations, and stories, fostering an interactive learning environment. Additionally, Codemao promotes collaboration through its dynamic online community, enhancing teamwork abilities among young learners.

dForce

Seed Round in 2020
dForce Network is a company that develops and operates a decentralized finance (DeFi) application, focusing on an integrated platform of open finance protocols. Founded in 2019 and based in China, dForce creates a suite of protocols, including stablecoin, liquidity, lending, and derivatives, enabling individuals to access various financial services without the need for traditional banking institutions or third parties. By leveraging blockchain technology, the company aims to foster an interconnected ecosystem that supports diverse financial services for both individuals and enterprises.

GIFT ADVISOR

Funding Round in 2020
GIFT ADVISOR is a gift selection tool with big data and artificial intelligence technology.

ArchForce Technology

Series B in 2020
ArchForce Technology, established in 2016, is a Shenzhen-based company that specializes in designing, developing, and providing core business systems and platforms for the securities and financial industry. Its product suite includes a message interconnection platform, a trading platform, a risk control system, and a trading highway, catering to the needs of securities firms, funds, banks, and insurance companies. The company's offerings support transactions, time clearing, risk management, speed markets, investment management, and wealth management marketing, contributing to the advancement of China's financial infrastructure.

North Ocean Photonics

Series B in 2020
North Ocean Photonics is a high-tech enterprise focusing on the field of micro-optics and optical integration.

Zhangshang Tangyi

Series D in 2020
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Huaqin Technology

Series B in 2019
Huaqin Technology Co Ltd is a leading player in the global smartphone and tablet original design manufacturing (ODM) industry. The company specializes in the research, development, design, and production of a wide range of intelligent hardware products, including smartphones, tablets, notebooks, servers, and IoT devices. As a partner of Google, Huaqin facilitates the creation of Android devices certified for security and functionality by Google Mobile Services. The company serves a diverse clientele across more than 100 countries and regions, focusing on delivering competitive and innovative products. By 2015, Huaqin had shipped over 200 million mobile phones and more than 5 million tablets annually, with a commitment to providing advanced 4G products. Guided by principles of integrity, diligence, focus, and innovation, Huaqin aims to enhance its product offerings and contribute to sustainable development in the technology sector.

Ultipa

Angel Round in 2019
Ultipa is a pioneering hard-tech company founded by experienced entrepreneurs from Silicon Valley, specializing in the development of advanced graph database technologies. The company has created the world's fastest 4th generation graph database system, aimed at transforming enterprise digital operations through graph-augmented intelligence. Ultipa's product offerings include the Ultipa Graph database, Ultipa Manager, and a suite of turnkey applications addressing various sectors such as Risk Management, Asset Liability Management, and Liquidity Management. By integrating graph computing and knowledge graph technologies, Ultipa enables organizations to extract maximum value from complex data sets, effectively replacing traditional relational databases and big-data frameworks. The company serves numerous prominent clients, including major banks, stock exchanges, and large enterprises. In November 2022, Ultipa launched Ultipa Cloud, a database-as-a-service and software-as-a-service version of its graph database, further enhancing its market presence.

Allystar Technology

Series A in 2019
Allystar Technology (Shenzhen) Co. Ltd. is a prominent designer of satellite navigation chipsets and application solutions, established in May 2013 as a spin-out from the GNSS chipsets designing department of China Electronics Corporation. The company became independent in December 2016 and is strategically located in Shenzhen, recognized as a key enterprise by the local government. With a capital investment of 400 million RMB from a joint venture involving various state-owned and social investors, Allystar specializes in the independent design, research and development, and sales of navigation and positioning chips, algorithms, and related products. The company's offerings cater to various markets, including consumer electronics, the automotive industry, national critical infrastructure, and the Internet of Things (IoT), ensuring comprehensive solutions for clients across these sectors.

iQuantex

Series A in 2019
iQuantex is a fintech company headquartered in Beijing, China, specializing in the development of an intelligent asset custodian and management platform. Founded in 2013, the company focuses on enhancing the investment management life cycle by offering comprehensive tools that cover various aspects, including investment product development, due diligence, execution, risk management, and post-deal analysis. The platform is designed to provide data-driven insights and integrated analytical tools, enabling money managers to increase both flexibility and efficiency in their investment processes.

Qihan Biotech

Series A in 2019
Qihan Biotech is a biomedical company specializing in genetic technology with a focus on addressing the global shortage of organ donors. The company aims to produce safe and effective cells, tissues, and organs for human transplantation using advanced gene editing techniques. By applying these technologies to xenogenic organ transplantation, Qihan Biotech seeks to create organs that can be transplanted into humans, thereby reducing the need for traditional organ transplants and saving lives.

Biocytogen

Series D in 2019
Biocytogen LLC is a biotechnology company based in Worcester, Massachusetts, that specializes in developing gene-targeted animal models for life science research. Founded in 2008, the company offers a range of services, including customized and off-the-shelf mouse models, phenotype analysis, and advanced gene-editing techniques. Its products encompass various types of mice, such as knockin and knockout models, as well as humanized mice, catering to diverse research areas including immunology, neurology, cancer, and infectious diseases. Biocytogen also operates a state-of-the-art animal facility to support its integrated platform for efficient antibody drug discovery and validation. The company collaborates with leading pharmaceutical and biotechnology firms to enhance preclinical research and development processes in the biomedical field.

Robosen

Series A in 2019
Robosen (Shenzhen) Co., Ltd., founded in 2008 and headquartered in Beijing, China, specializes in the development and manufacturing of intelligent robotics. The company offers a variety of products, including educational robots, vending robots, and smart fighting robots, aimed at enhancing convenience in daily life. One of its notable innovations, the "Pathfinder Pioneer," features the ability to store up to 1 million action programs and can transform between a human and a jeep shape. This product also supports mobile app control and visual 3D programming via a PC. Robosen's technology encompasses advanced features such as digital electric transmission, servo motors, artificial joints, and body language recognition, positioning the company as a key player in the consumer robotics market.

Tencent Trusted Doctors

Series C in 2019
Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".

InventisBio

Series C in 2019
InventisBio Inc. is a biotechnology company focused on discovering and developing innovative therapeutics for cancer and metabolic diseases. Founded in 2013 and based in Pudong, China, the company has developed a range of small molecule drug candidates targeting lung cancer, breast cancer, and gout. Among its notable products is D-0316, a third-generation EGFR-T790M tyrosine kinase inhibitor. InventisBio is also engaged in creating targeted immuno-oncology therapies that can be used in combination with existing treatments, such as PD-1 antibodies, to address various cancer indications. Co-founded by Dr. Yaolin Wang and a team of scientists with extensive experience in drug discovery at major pharmaceutical companies, InventisBio aims to provide effective therapies for significant health challenges.

Burning Rock

Series C in 2019
Burning Rock Biotech Limited specializes in developing and providing cancer therapy selection tests in the People's Republic of China. The company offers a range of next-generation sequencing-based tests applicable to various cancer types, using both tissue and liquid biopsy samples. Its principal products include OncoScreen Plus for therapy and immunotherapy guidance, LungPlasma for non-small cell lung cancer, ColonCore for gastrointestinal cancers, and HRDCore for homologous recombination deficiency. Burning Rock collaborates with major pharmaceutical companies for clinical trials and research studies, primarily through central laboratory and companion diagnostics services. The company, founded in 2014, is headquartered in Guangzhou, China, with a focus on providing individualized cancer treatment guidance using medical and bioinformatics technologies.

Apollomics

Series B in 2019
Apollomics, Inc. is an emerging life sciences company based in Foster City, California, focused on developing innovative oncology therapies aimed at targeting the growth and proliferation of cancer cells. Founded in 2016, the company’s pipeline includes several development-stage assets, such as CBT-101, an oral agent that targets the epithelial to mesenchymal transition pathway associated with various tumors, and CBT-102, which inhibits the MAP Kinase pathway and angiogenesis through its effects on specific receptors. Additionally, Apollomics is advancing monoclonal antibodies CBT-501 and CBT-502, which target the PD-1 and PDL-1 membrane receptors, respectively, to enhance the immune response against cancer. By combining immune-based strategies with targeted therapies, Apollomics aims to develop novel treatments that can effectively combat cancer.

Bellen

Series C in 2018
Bellen Chemistry is a premier provider of a variety of heterocycles. Our activity is focused on the design and development of novel molecules,6361413375267061158256368.jpgintermediates for the Chemical and Pharmaceutical industries. Bellen Chemistryhas a strong R&D team with a talent pool of 200+ trained scientists. We have excellent track records, as we deliver unrivalled chemical innovation to our customers worldwide.

Tianrang

Series A in 2018
Tianrang, founded in June 2016 and headquartered in Shanghai, is dedicated to creating a comprehensive platform for universal artificial intelligence. The company leverages advanced AI technologies, including deep learning and machine learning, to assist enterprises, government agencies, and individuals in developing proprietary AI engines that address various operational challenges. Tianrang's solutions span multiple sectors, such as commercial operations, urban management, finance, and education. Notably, the company has developed intelligent optimization products for online marketing, which have successfully enhanced merchants' marketing effectiveness. Additionally, Tianrang's urban brain initiative utilizes AI to optimize city traffic signals, improving overall traffic flow. The company also provides Go training through its advanced AI program, which has achieved world championship-level performance in the game. With branches in Hangzhou and Guangzhou, Tianrang's team comprises experts from prestigious universities and leading tech companies, bringing extensive experience in machine learning and AI research.

CMC

Series A in 2018
CMC Inc. is a Chinese state-backed media and entertainment conglomerate established in 2010. The company specializes in producing a diverse range of content across multiple genres, including film, drama, financial media, music, and sports. CMC's broad portfolio reflects its commitment to cultural and creative industries, positioning it as a significant player in the Chinese media landscape. With a focus on innovation and quality, CMC Inc. aims to leverage its resources to enhance the development of the entertainment sector in China and beyond.

Cambricon Technologies

Series B in 2018
Cambricon Technologies is a leading innovator in the development of artificial intelligence core chips, focusing on applications in cloud servers, edge computing, and various terminal devices. Founded by Professor Chen Tianshi, a distinguished scientist in processor architecture and artificial intelligence, the company has established itself as a pioneer in smart chip technology. Cambricon is recognized for its groundbreaking products, including the Cambrian-1A processor, which was the first commercial deep learning processor designed for a range of terminal equipment such as smartphones, wearable devices, and autonomous vehicles. With two main product lines—terminal and server—Cambricon provides customers with a diverse array of chip products and system software solutions, positioning itself at the forefront of the AI chip industry.

OncXerna Therapeutics

Seed Round in 2018
OncXerna Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for cancer patients by utilizing an RNA-based biomarker platform. The company aims to improve patient outcomes by prospectively identifying individuals based on the unique RNA biology of their tumor microenvironments. This innovative approach enables OncXerna to match patients with targeted oncology therapies that correspond to their specific tumor characteristics. Founded in 2018 and based in Waltham, Massachusetts, with an additional location in Shanghai, China, OncXerna was formerly known as Oncologie, Inc. and changed its name in September 2020 to reflect its commitment to advancing next-generation precision medicine for a broader range of cancer patients.

Codemao

Series C in 2018
Codemao is an online education platform focused on teaching children the fundamentals of computer coding. Established in 2015 in Shenzhen, Guangdong, by Tianchi Li and Yue Sun, Codemao utilizes a proprietary visual programming tool that enables students to engage with coding through gamified courses. This innovative approach combines digital learning with various disciplines, allowing children to grasp programming concepts while developing their logical thinking and creative skills. The platform facilitates the creation of games, software, animations, and stories, fostering an interactive learning environment. Additionally, Codemao promotes collaboration through its dynamic online community, enhancing teamwork abilities among young learners.

Lvkon.com

Series B in 2018
Suzhou Lvkon Transmission Technology Co., Ltd. specializes in the research, development, production, and sales of advanced automotive technologies. Founded in 2011 and based in Suzhou, China, the company focuses on automotive AMT automatic transmissions, new energy vehicle drive motors, and powertrains for both pure electric and hybrid vehicles. Lvkon.com is dedicated to enhancing the energy efficiency, comfort, and overall performance of new energy vehicles through innovative technology and comprehensive product development. The firm excels in key areas such as new energy vehicle control, power system integration, and the independent design and manufacture of crucial components like transmissions and motors. By combining high-tech innovations with a commitment to quality, Lvkon.com aims to serve high-end markets and establish itself as a leader in the new energy vehicle sector.

Roadstar.AI

Series A in 2018
Roadstar.AI is a startup based in Silicon Valley and Shenzhen, founded by experts in robotics and machine learning with backgrounds at prominent companies such as Google, Tesla, Nvidia, Apple, and Baidu. The company specializes in developing autonomous driving technology aimed at enhancing transportation safety, efficiency, and accessibility. Roadstar.AI employs a unique multi-sensor fusion framework that ensures accurate time and spatial synchronization, enabling real-time updates and robust feature extraction from high-dimensional raw data. This technology is designed to create a safer and more enjoyable travel experience for both cars and trucks, contributing to the evolution of advanced transportation systems.

Biocytogen

Series C in 2018
Biocytogen LLC is a biotechnology company based in Worcester, Massachusetts, that specializes in developing gene-targeted animal models for life science research. Founded in 2008, the company offers a range of services, including customized and off-the-shelf mouse models, phenotype analysis, and advanced gene-editing techniques. Its products encompass various types of mice, such as knockin and knockout models, as well as humanized mice, catering to diverse research areas including immunology, neurology, cancer, and infectious diseases. Biocytogen also operates a state-of-the-art animal facility to support its integrated platform for efficient antibody drug discovery and validation. The company collaborates with leading pharmaceutical and biotechnology firms to enhance preclinical research and development processes in the biomedical field.

Eucure Biopharma

Series B in 2018
Eucure Biopharma, established in 2016 and headquartered in Beijing, China, is a biotechnology company focused on the discovery and development of innovative immuno-oncology targeted antibodies. Its pipeline comprises eight drug candidates, primarily targeting immune checkpoints, with several in the clinical trial application stage. The company offers services such as antibody production, in vivo and in vitro drug efficacy testing, and aims to improve the survival rate of tumor patients by developing effective antibody treatments.

LP Pharmaceuticals

Series B in 2017
LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.

Douyu TV

Series D in 2017
Douyu International Holdings Limited operates a live streaming platform based in Wuhan, China, focusing primarily on interactive gaming and entertainment content. Founded in 2014, the platform connects various stakeholders, including game developers, professional eSports teams, advertisers, and viewers. Douyu TV features a wide range of live streaming options, encompassing not only video games but also sports, variety shows, music, and travel content. The platform enables users to submit, view, and comment on videos, while also providing features for recording and sharing clips of live broadcasts. Douyu TV plays a significant role in the eSports ecosystem by sponsoring teams and organizing tournaments, positioning itself as a key player in the live streaming and gaming sectors in China.

Souche

Series E in 2017
Souche, founded by Yao Junhong in December 2012, is a prominent automotive new retail platform in China. The company has attracted significant investments, raising over $1.2 billion by August 2018 from notable organizations such as Alibaba Group and Ant Financial Services Group. Recognized in the 2017 New Global Unicorns Ranking by PitchBook, Souche aims to be a central intelligence hub for the automotive industry. Over the years, it has developed an integrated automotive retail ecosystem that includes various businesses. These encompass Tangeche, an automotive financial leasing platform; Chehang168, a B2B industrial chain service platform; Cheyipai, an online used-car trading platform; and TIHD, a car-sharing service. Additionally, Souche offers SaaS products for used-car dealers through Dafengche and operates a new-car dealership network called Maicheguanjia. The company also provides ERP systems for dealership groups and integrated supply chain logistics services. Souche is often referred to as "the Alibaba of the Chinese automotive industry."

United Imaging Healthcare

Series A in 2017
United Imaging Healthcare develops and manufactures a wide range of medical equipment and solutions, focusing on diagnostic imaging, radiotherapy, and healthcare information technology. The company's product offerings include advanced imaging devices such as computed tomography, molecular imaging, magnetic resonance systems, and digital radiography solutions. Notable products include the uCT 510, uMI 510 PET-CT scanner, and uMR 560 imaging device. Additionally, United Imaging provides the uCloud UIH Intelligent Medical Cloud platform for resource sharing and data analysis. The company also offers comprehensive customer support, technical assistance, and training services. Established in 2011 and headquartered in Shanghai, China, United Imaging Healthcare has expanded its operations to various locations, including the United States, with facilities in cities like Concord, Cleveland, and Houston. The company has strategic partnerships to enhance its offerings and reach in the healthcare sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.